OXA-204 Carbapenemase in Clinical Isolate of Pseudomonas guariconensis, Tunisia

OXA-204 Carbapenemase in Clinical Isolate of Pseudomonas guariconensis, Tunisia

We report an OXA-204–producing Pseudomonas guariconensis clinical isolate in Tunisia, proving the spread of OXA-48 variants beyond Enterobacterales. The blaOXA-204 gene was carried on a 119-kb chromosomally integrated plasmid fragment, along with multiple additional resistance genes. Surveillance,...

Full description

Saved in:
Bibliographic Details
Main Authors: Nadia Jaidane, Wejdene Mansour, Lamia Tilouche, Pierre Châtre, Pauline François, Agnese Lupo, Saoussen Oueslati, Aymeric Jacquemin, Ali Lazzem, Sonia Karaborni, Laetitia Du Fraysseix, Yomna Ben Lamine, Nidhal Mahdhi, Abdelhalim Trabelsi, Jean-Yves Madec, Marisa Haenni, Thierry Naas
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2025-06-01
Series:Emerging Infectious Diseases
Subjects:
Pseudomonas guariconensis
OXA-204
carbapenemase
CMY-16
burn unit
bacteria
Online Access:https://wwwnc.cdc.gov/eid/article/31/6/25-0131_article
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://wwwnc.cdc.gov/eid/article/31/6/25-0131_article

Similar Items